Sai Parenteral’s IPO Review: GMP, Price Band, Dates, Allotment & Valuation Analysis
Updated on 02.04.2026|11:14 AMSai Parenteral’s Limited is set to launch its Initial Public Offering (IPO). It is a diversified pharmaceutical formulations company with robust research, development, and manufacturing capabilities in both Branded Generics and Contract Development and Manufacturing Organisation (CDMO) services.The public issue will open for subscription on Tuesday, March 24, 2026, and close on Friday, […]
Sai Parenteral’s IPO Review: GMP, Price Band, Dates, Allotment & Valuation Analysis Read More »




